Our story

In 2014 I caused sepsis in two patients the same week. It was clear to me that those infections arose from bacterial transfer by the biopsy needle. But when I looked for safer options there were none to buy for my department. At the same time my needle deviated AWAY from the tumour in target biopsies. Knowing there had to be a better way, I got to work.

Ten years later I’m very proud to present the Forsvall Biopsy system: Made to facilitate you hitting your targets in both TR and TP biopsies*, while reducing bacterial transfer by 96%**. Proven non inferior biopsy cores***, easy to use with that premium feel. Try the difference! You and your patients deserve it.

Andreas Forsvall, MD
Surgeon and Urologist, PhD, CEO and Founder of Xaga Surgical. Member American Urological Association, Fellow on the European Board of Urology.

** A.Forsvall, M. Utter, M. Wagenius, A0758 – Precision in targeted prostate biopsy: A comparative in-vitro study of a novel needle design vs. Tru-Cut needle, European Urology, Volume 87, Supplement 2, 2025, Page S1595, ISSN 0302-2838,
https://doi.org/10.1016/j.eururo.2025.09.3944
**PMID: 33999753
***PMID: 33999764

Our core team leads strategy, operations, and commercialization, driving Xaga Surgical forward every day.

Team

  • Andreas Forsvall, MD

    CEO & Founder

    Practicing urologist and inventor of the Forsvall Needle. Founded Xaga Surgical in 2016 to improve prostate cancer diagnostics and reduce biopsy-related infections.

  • Martin Ekenbäck

    COO

    Extensive leadership experience from startup and scaleup companies like Tink (acquired by Visa 2021), Nepa (IPO 2016) and Hemma, with a previous background at McKinsey & Co. With Xaga since 2024.

  • Tobias Fritz

    Interim QA/RA Manager

    Experienced medtech professional with over 15 years in quality, regulatory, and operations, including leadership roles at Aptio Group, Acarix (CTO), Dignitana (COO) and JAFO. With Xaga Surgical since 2025..

  • Ola Carmonius

    Engineering Consultant

    Senior mechanical engineer with 20+ years in product design, including roles at Perlos, Sony Ericsson, Scalae, Altran, and now Devino Group AB. With Xaga since 2020.

Our consulting partners strengthen us with specialized expertise in research, product development, and production.

Consulting Partners

  • Jane Fisher

    Research Consultant

    Co-Founder of AdvanSci Research Solutions with extensive experience in clinical and pre-clinical research. With Xaga since 2016, she has contributed to translational research, study design, and scientific writing.

  • Mats Edberg

    Product Development Consultant

    Product development consultant and founder of Edberginnovation AB, with long experience in prototypes and medical device innovation. With Xaga since 2016.

  • Din Sirco

    Production Consultant

    Founder of AdvaMach AB with extensive experience in CNC programming and machining. With Xaga since 2022, he supports precision manufacturing and production.

Our board combines entrepreneurial leadership, healthcare expertise, and investment experience to guide Xaga Surgical’s long-term strategy.

Board of Directors

  • Carl Jansson 

    Chairman

    Chairman of Carl Westin and Blodtrycksdoktorn. Board Member of Pley and PinMeTo. Former CMO (commercial lead) at MEDS Apotek and Min Doktor.

  • Anna Lindström

    Board Member

    Founder and CEO of Caiator, Board Member of Flowcup AB and Grön Aurora AB. With Xaga since 2016, she brings international sales, marketing, and business development experience from Alfa Laval, Barry Callebaut, Alufluor, and Invent Medic.

  • Christian W. Jansson

    Board Member

    Board Member at Meds Apotek AB, Excillum AB, Blodtrycksdoktorn AB, and Carl Westin AB. Former Chair of PostNord AB, Apoteket, Min Doktor and Svensk Handel. Former CEO of Kappahl, Ellos, and Europris. With Xaga since 2020.

  • Faten Mustafa

    Board Member

    Board member in several companies and an active investor focused on developing scalable businesses. With her experience and strong strategic and commercial background, she creates value in growth-stage companies and across investment portfolios.

  • Andreas Forsvall, MD

    CEO & Founder

    Practicing urologist and inventor of the Forsvall Needle. Founded Xaga Surgical in 2016 to improve prostate cancer diagnostics and reduce biopsy-related infections.

Our advisory board provides strategic guidance based on deep experience in medtech entrepreneurship, commercialization, and global expansion.

Advisory board

  • Dan Pitulia

    Senior Advisor

    Dan is CEO of Atlas Antibodies and Chairman of Neoventa Medical, where he has been engaged since 2010. He also serves on the board of QleanAir Scandinavia AB. Previously, he was CEO of Coala Life, Memira, QleanAir Scandinavia, Carmel Pharma (sold to BD 2011), and Entific Medical Systems (sold to Cochlear 2005). With Xaga since 2020, he brings extensive experience in leading international medtech companies through growth, transformation, and successful exits. With Xaga since 2020.

  • Peter Sebelius

    Senior Advisor

    Founder and CEO of Medical Device HQ AB. Former CEO of Vivoline Medical AB, Chair of Neurescue ApS, and Board Member of EYE-GO A/S. With Xaga since 2016. Involved in medical device standardisation with ISO since 2010.

Supporting partners

Investor relations

For investor relations please reach out to COO Martin Ekenbäck.

Send e-mail

Certificates & Awards

1

U.S. FDA 510(k)

Clearance for the Forsvall Biopsy Needle System (K242128) registration for use in the U.S.

2

ISO 13485:2016

Ensuring the highest standards of quality and safety in medical devices

3

Best abstract

By Engineering & Urology Society, AUA Annual Meeting 2025, Las Vegas

4

Top ten most promising global startups

In urology by AUA | Innovation Nexus, AUA Annual Meeting 2024, Baltimore

5

Best abstract

By International Prostate Cancer Update 2023, Vail, Colorado